Free shipping on all orders over $ 500

 About 1 result found for searched term "1350624-75-7" (0.307 seconds)

Cat.No.  Name Target
M24621 Margetuximab EGFR/HER2
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.